iCAD Announces Distribution Agreement with Hitachi For MR Image Analysis and Guided Biopsy Solution

NASHUA, N.H., Oct 31, 2011 (BUSINESS WIRE) -- iCAD, Inc. ICAD +2.82% , an industry-leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of cancer, today announced that it has entered into a distribution agreement with Hitachi Medical Systems. With this agreement, iCAD's SpectraLook with PrecisionPoint image analysis solution for breast MRI will be available for purchase with Hitachi's Oasis and Echelon MRI systems. iCAD's MRI solution will assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of MRI studies and streamline the planning and performance of MRI-guided percutaneous breast biopsies.

"Dynamic MRI is being utilized with increased frequency as a less-invasive way to identify cancer at an early stage," said Ken Ferry, President and CEO of iCAD. "With this agreement, iCAD's advanced image analysis technology will be available to assist the many clinicians using Hitachi's MR systems to increase diagnostic confidence -- allowing them to more accurately and quickly assess a tumor, which should lead to more targeted treatment options for their patients."

source: Market Watch

1 comment:

Dr. Clark Store said...

WOW!!! I think its a great agreement it can provide a bit of relief to the patients!!!

Hulda Clark